112 related articles for article (PubMed ID: 685891)
41. Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen.
ten Dam K; de Groot IJ; Noordam C; van Alfen N; Hendriks JC; Sie LT
Neuromuscul Disord; 2012 Jun; 22(6):500-4. PubMed ID: 22390890
[TBL] [Abstract][Full Text] [Related]
42. Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy.
Chesney RW; Moorthy AV; Eisman JA; Jax DK; Mazess RB; DeLuca HF
N Engl J Med; 1978 Feb; 298(5):238-42. PubMed ID: 201843
[TBL] [Abstract][Full Text] [Related]
43. Whole body bone mineral content in healthy children and adolescents.
Mølgaard C; Thomsen BL; Prentice A; Cole TJ; Michaelsen KF
Arch Dis Child; 1997 Jan; 76(1):9-15. PubMed ID: 9059153
[TBL] [Abstract][Full Text] [Related]
44. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
Lampit M; Hochberg Z
J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
[TBL] [Abstract][Full Text] [Related]
45. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
46. [The effect of long-term low dose prednisone on bone mineral density in patients with systemic lupus erythematosus].
Wang G; Li XP; Li XM; Wang GS; Tao JH; Ma Y
Zhonghua Nei Ke Za Zhi; 2017 Mar; 56(3):179-183. PubMed ID: 28253597
[No Abstract] [Full Text] [Related]
47. [Effects of inhaled beclomethasone on height growth and bone metabolism in children with asthma].
Inoue T; Doi S; Takamatsu I; Murayama N; Kameda M; Hayashida M; Nishida M; Toyoshima K
Arerugi; 1995 Jul; 44(7):678-84. PubMed ID: 7575133
[TBL] [Abstract][Full Text] [Related]
48. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
Górska A; Urban M; Konstantynowicz J; Bartnicka M; Chlabicz S; Górski S; Kaczmarski M
Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
[TBL] [Abstract][Full Text] [Related]
49. Bone mineral status in growth hormone deficiency.
Shore RM; Chesney RW; Mazess RB; Rose PG; Bargman GJ
J Pediatr; 1980 Mar; 96(3 Pt 1):393-6. PubMed ID: 7359231
[TBL] [Abstract][Full Text] [Related]
50. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
[TBL] [Abstract][Full Text] [Related]
51. Bone mineral status in childhood accidental fractures.
Chan GM; Hess M; Hollis J; Book LS
Am J Dis Child; 1984 Jun; 138(6):569-70. PubMed ID: 6720643
[TBL] [Abstract][Full Text] [Related]
52. Effect of puberty on rates of bone growth and mineralisation: with observations in male delayed puberty.
Krabbe S; Christiansen C; Rødbro P; Transbøl I
Arch Dis Child; 1979 Dec; 54(12):950-3. PubMed ID: 533299
[TBL] [Abstract][Full Text] [Related]
53. Reduced bone mineral content in totally thyroidectomized patients: possible effect of calcitonin deficiency.
McDermott MT; Kidd GS; Blue P; Ghaed V; Hofeldt FD
J Clin Endocrinol Metab; 1983 May; 56(5):936-9. PubMed ID: 6833470
[TBL] [Abstract][Full Text] [Related]
54. Demineralization in cystic fibrosis detected by direct photon absorptiometry.
Mischler EH; Chesney PJ; Chesney RW; Mazess RB
Am J Dis Child; 1979 Jun; 133(6):632-5. PubMed ID: 443220
[TBL] [Abstract][Full Text] [Related]
55. Bone mineral content deficits of the spine and whole body in children at time of diagnosis with celiac disease.
Jatla M; Zemel BS; Bierly P; Verma R
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):175-80. PubMed ID: 19179879
[TBL] [Abstract][Full Text] [Related]
56. Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease.
Toh SH; Claunch BC; Brown PH
J Clin Endocrinol Metab; 1983 Feb; 56(2):405-9. PubMed ID: 6822644
[TBL] [Abstract][Full Text] [Related]
57. Bone mineral density and bone metabolism in Duchenne muscular dystrophy.
Bianchi ML; Mazzanti A; Galbiati E; Saraifoger S; Dubini A; Cornelio F; Morandi L
Osteoporos Int; 2003 Sep; 14(9):761-7. PubMed ID: 12897980
[TBL] [Abstract][Full Text] [Related]
58. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
[TBL] [Abstract][Full Text] [Related]
59. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[TBL] [Abstract][Full Text] [Related]
60. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
Girgis R; Winter JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
